AI assistant
Sending…
60 DEGREES PHARMACEUTICALS, INC. — Director's Dealing 2023
Jul 12, 2023
35377_dirs_2023-07-11_2753acf6-7dc8-41bb-bd5f-51100e8d14f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
CIK: 0001946563
Period of Report: 2023-07-11
Reporting Person: MILLER TYRONE (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 101928 | Direct |
More from 60 DEGREES PHARMACEUTICALS, INC.
Regulatory Filings
2026
Jun 3
Board/Management Information
2026
May 18
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Mar 20
Delisting Announcement
2026
Feb 12
Delisting Announcement
2026
Jan 23
Capital/Financing Update
2026
Jan 21
Investor Presentation
2026
Jan 8
Director's Dealing
2025
Dec 16
Director's Dealing
2025
Dec 12